Oval Fertility, a next-gen fertility platform built at the intersection of advanced reproductive science and technology, has announced the launch of its flagship clinic in Hyderabad.
Oval Fertility introduces Astec Chrono, Japan’s advanced embryo incubation technology, to India, designed to closely mimic natural developmental conditions while allowing embryologists to monitor embryo development continuously without disturbing growth conditions, enabling more informed clinical decisions.
The Hyderabad facility houses 6 embryology workstations, 7 suites and 5 recovery rooms as Sanctuaries and is designed to support approximately 800 fertility cycles annually, strengthening access to advanced reproductive care in the region.
Entrepreneur and patient advocate Veena Reddy, alongside Dr. Brian Levine, a globally recognized leader in IVF and infertility with nearly 15 years of experience working with the most challenging IVF cases, together built Oval, shaped by advanced technology and medical excellence. The launch comes at a time when fertility healthcare demand continues to rise globally and in India, driven by factors including delayed parenthood, lifestyle shifts, stress-related conditions and increasing awareness around reproductive health.
The leadership includes internationally recognised fertility specialist Dr. Brian Levine, Founding Medical Advisor of Oval Fertility, alongside Dr. Sandeep Karunakaran, Medical Director with over three decades of experience, and Dr. Keerthana Vemula, Reproductive Endocrinologist with over 12 years of expertise in fertility care.
Speaking about the launch, Dr. Brian Levine, Founding Medical Advisor, Oval Fertility, said, “At Oval, we have built an ecosystem designed to bring global clinical expertise, advanced reproductive technologies and precision-driven decision making together, while ensuring patients feel informed, supported and empowered throughout their journey.”
Oval offers comprehensive reproductive healthcare services for male & female fertility under one roof, including IVF (In Vitro Fertilisation), ICSI (Intracytoplasmic Sperm Injection), Comprehensive Fertility Assessments, Oncofertility care, Preimplantation Genetic Testing, among others.
“Building Oval alongside Dr. Levine allowed us to bring together global medical expertise and patient perspective to create a fertility platform designed around both clinical excellence and human experience,” said Ms. Veena Reddy, Co-founder, Oval Fertility.
Positioned in Hyderabad and backed by GVK, decades of legacy in Infrastructure, Energy, Healthcare and Lifesciences, with the same vision, Oval is reshaping the future of fertility. Oval Fertility aims to serve patients not only across India but also international families seeking advanced fertility treatment options.
